SCHEMBL6896787

SCHEMBL6896787

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C(O)C1OCCCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 10/20 0.65
▸ ADORA1 P30542 7/20 0.65
▸ ADORA3 P0DMS8 7/20 0.65
▸ ADORA2B P29275 6/20 0.65
▸ SLC29A1 Q99808 2/20 0.62
▸ DPP4 P27487 1/20 0.62
▸ MEN1 O00255 1/20 0.62
▸ SLC28A1 O00337 1/20 0.62
▸ MAP3K7 O43318 1/20 0.62
▸ SLC28A2 O43868 1/20 0.62
▸ GAPDH P04406 1/20 0.62
▸ MAPK1 P28482 1/20 0.62
▸ STAT6 P42226 1/20 0.62
▸ PI4KA P42356 1/20 0.62
▸ KMT2A Q03164 1/20 0.62
▸ SMN1; SMN2 Q16637 1/20 0.62
▸ PI4K2B Q8TCG2 1/20 0.62
▸ DOT1L Q8TEK3 1/20 0.62
▸ PI4K2A Q9BTU6 1/20 0.62
▸ SLC28A3 Q9HAS3 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6896781 1.00 ADORA2A (0.65) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL6896080 0.90 ADORA1 (0.66) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL6896076 0.90 ADORA1 (0.66) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL6896932 0.89 ADORA2A (0.60) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL6896935 0.89 ADORA2A (0.60) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL5980036 0.87 ADORA3 (0.69) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL14425024 0.87 ADORA3 (0.69) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL5980045 0.87 ADORA3 (0.69) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL6898304 0.86 ADORA2A (0.63) ADORA2AADORA1ADORA3ADORA2BSLC29A1
SCHEMBL6898295 0.86 ADORA2A (0.63) ADORA2AADORA1ADORA3ADORA2BSLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0604409-B1 OLIGONUCLEOTIDE ANALOGS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION ISIS PHARMACEUTICALS INC (US) 2004-07-14 — — EP disclosed
EP-1418179-A2 Compositions and methods for detecting and modulating rna activity and gene expression ISIS PHARMACEUTICALS, INC. (US) 2004-05-12 — — EP disclosed
US-6262241-B1 ANTISENSE COMPOUNDS WHICH CLEAVE PHOSPHORODIESTER BONDS AND IMPROVE PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES OF OLIGONUCLEOTIDES, USEFUL IN DIAGNOSING DISEASES ISIS PHARMACEUTICALS, INC. 2001-07-17 — — US disclosed
Send feedback